Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Current Drug Discovery Technologies|March 31, 2023
Exploring the Molecular Structural Requirements of Flavonoids as Beta- Secretase-1 Inhibitors Using Molecular Modeling StudiesUttam A More, Malleshappa N Noolvi, Devendra Kumar, et al.Expert Opinion on Drug Delivery|March 22, 2014
Guar gum as platform for the oral controlled release of therapeuticsTejraj M Aminabhavi, Mallikarjuna N Nadagouda, Shrinivas D Joshi, et al.Chemical Biology & Drug Design|November 1, 2016
Graph theoretical analysis, insilico modeling, design, and synthesis of compounds containing benzimidazole skeleton as antidepressant agentsPanneerselvam Theivendren, Arumugam Subramanian, Indhumathy Murugan, et al.European Journal of Medicinal Chemistry|November 19, 2013
Synthesis, biological evaluation and docking studies of 4-aryloxymethyl coumarins derived from substructures and degradation products of vancomycinHrishikesh M Revankar, Manohar V Kulkarni, Shrinivas D Joshi, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 22, 2014
Polysaccharide-based micro/nanohydrogels for delivering macromolecular therapeuticsKuntal Ganguly, Kiran Chaturvedi, Uttam A More, et al.Journal of Pharmaceutical Analysis|February 7, 2018
Multi-spectroscopic investigation of the binding interaction of fosfomycin with bovine serum albuminManjunath D Meti, Sharanappa T Nandibewoor, Shrinivas D Joshi, et al.Bioorganic Chemistry|March 25, 2015
Synthesis, evaluation and in silico molecular modeling of pyrroyl-1,3,4-thiadiazole inhibitors of InhAShrinivas D Joshi, Uttam A More, Deepshikha Koli, et al.European Journal of Medicinal Chemistry|March 16, 2015
Discovery of target based novel pyrrolyl phenoxy derivatives as antimycobacterial agents: an in silico approachUttam A More, Shrinivas D Joshi, Tejraj M Aminabhavi, et al.European Journal of Medicinal Chemistry|December 3, 2013
Design, synthesis, molecular docking and 3D-QSAR studies of potent inhibitors of enoyl-acyl carrier protein reductase as potential antimycobacterial agentsUttam A More, Shrinivas D Joshi, Tejraj M Aminabhavi, et al.Mini Reviews in Medicinal Chemistry|August 21, 2014
Enoyl ACP reductase as effective target for the synthesized novel antitubercular drugs: a-state-of-the-artShrinivas D Joshi, Sheshagiri R Dixit, Uttam A More, et al.Pageof 2